Category Archive: NASDAQ:AMGN

Harvard Professor’s Attack On Pharma’s Clinical Trials Is Absurd

Yes, we must be vigilant to be certain that studies are run ethically and that results are published accurately and on time. But, to say that academic-industry relationships are full of “corruption” is both wrong and irresponsible.

Two Mistakes Investors Make When Investing In Biotechnology Companies

Biotechnology stocks were some of the strongest performing stocks from 2009-2015. Then, the biotech bubble burst and just about every major biotech stock plunged into a private bear market.

Explore the Archive